Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: A phase II study

AIM: To evaluate the safety of adding ketoprofen to pegylated-interferon (PEG-IFN) with or without ribavirin and the effect on viral kinetics, STAT1 activity and expression of 2’-5’-oligoadenylate synthetase (2’-5’OAS) in genotype 1 chronic hepatitis C in a phase II study. METHODS: Forty-five patien...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gramenzi, Annagiulia, Cursaro, Carmela, Margotti, Marzia, Balsano, Clara, Spaziani, Alessandra, Anticoli, Simona, Loggi, Elisabetta, Salerno, Maddalena, Galli, Silvia, Furlini, Giuliano, Bernardi, Mauro, Andreone, Pietro
Format: Artigo
Idioma:Inglês
Publicat: The WJG Press and Baishideng 2009
Matèries:
Brief Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2795181/
https://ncbi.nlm.nih.gov/pubmed/20014458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.5946
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars